• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Resection for Klatskin tumors: technical complexities and results.肝门部胆管癌切除术:技术复杂性与结果
Transl Gastroenterol Hepatol. 2018 Sep 18;3:69. doi: 10.21037/tgh.2018.09.01. eCollection 2018.
2
Diagnostic and surgical features of Klatskin tumors.肝门部胆管癌的诊断与手术特征。
Chir Ital. 1999 Jan-Feb;51(1):1-7.
3
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
4
Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.肝门部胆管癌手术的进展显示预后改善:一项单中心分析
Tumori. 2014 Nov-Dec;100(6):e250-6. doi: 10.1700/1778.19288.
5
Limits of Surgical Resection for Bile Duct Cancer.胆管癌手术切除的局限性
Viszeralmedizin. 2015 Jun;31(3):189-93. doi: 10.1159/000433482. Epub 2015 Jun 11.
6
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.肝内胆管细胞癌(ICC)扩大肝切除术:何时值得进行?一项单中心5年期间对50例患者进行27例切除术的经验。
Ann Surg. 2005 Jan;241(1):134-43. doi: 10.1097/01.sla.0000149426.08580.a1.
7
Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma.肝门部胆管癌患者肝切除术后肝功能衰竭的风险预测。
J Gastroenterol Hepatol. 2018 Apr;33(4):958-965. doi: 10.1111/jgh.13966. Epub 2018 Jan 26.
8
[Application of perihilar surgical techniques in perihilar biliary tract tumours].[肝门部外科技术在肝门部胆管肿瘤中的应用]
Zhonghua Wai Ke Za Zhi. 2018 May 1;56(5):332-337. doi: 10.3760/cma.j.issn.0529-5815.2018.05.003.
9
Klatskin tumor: Diagnosis, preoperative evaluation and surgical considerations.肝门部胆管癌:诊断、术前评估及手术考量
Cir Esp. 2015 Nov;93(9):552-60. doi: 10.1016/j.ciresp.2015.07.003. Epub 2015 Aug 19.
10
Major hepatectomies for perihilar cholangiocarcinoma: Predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions.肝门部胆管癌的大范围肝切除术:依据国际肝脏手术研究组的定义分析临床相关术后并发症的预测因素
Asian J Surg. 2016 Apr;39(2):81-9. doi: 10.1016/j.asjsur.2015.04.007. Epub 2015 Jun 20.

引用本文的文献

1
Prognostic Significance of Sarcopenia in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.肌少症在肝门部胆管癌手术患者中的预后意义:一项系统评价和荟萃分析
Cancers (Basel). 2025 Feb 28;17(5):837. doi: 10.3390/cancers17050837.
2
Klatskin tumor - A case report of hilar cholangiocarcinoma with hepatic metastasis.克氏壶腹肿瘤——1例伴有肝转移的肝门部胆管癌病例报告。
Int J Surg Case Rep. 2025 Mar;128:111051. doi: 10.1016/j.ijscr.2025.111051. Epub 2025 Feb 12.
3
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.比较不可切除局部疾病行 R1 切除与姑息化疗后肝门部胆管癌的生存情况。
Ann Surg Oncol. 2024 Oct;31(10):6495-6503. doi: 10.1245/s10434-024-15582-5. Epub 2024 Jun 19.
4
Short-term and long-term clinical outcomes of combined major vessel resection for hilar cholangiocarcinoma: a propensity score analysis.肝门部胆管癌联合主要血管切除的短期和长期临床结局:一项倾向评分分析
Ann Surg Treat Res. 2023 Nov;105(5):319-332. doi: 10.4174/astr.2023.105.5.319. Epub 2023 Oct 31.
5
Effect of sarcopenia on postoperative ICU admission and length of stay after hepatic resection for Klatskin tumor.肌肉减少症对肝门部胆管癌肝切除术后入住重症监护病房及住院时间的影响。
Front Oncol. 2023 Mar 9;13:1136376. doi: 10.3389/fonc.2023.1136376. eCollection 2023.
6
Alveolar Echinococcosis-A Challenging Task for the Hepatobiliary Surgeon.肺泡型肝包虫病——肝胆外科医生面临的一项具有挑战性的任务。
Pathogens. 2021 Dec 31;11(1):40. doi: 10.3390/pathogens11010040.
7
Vascular Resection in Perihilar Cholangiocarcinoma.肝门部胆管癌的血管切除
Cancers (Basel). 2021 Oct 21;13(21):5278. doi: 10.3390/cancers13215278.
8
Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma.黄疸的累积损伤效应可能是Ⅱ型及以上肝门部胆管癌根治性切除患者并发症的有效预测指标。
Ann Transl Med. 2021 May;9(10):861. doi: 10.21037/atm-21-1860.
9
Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review.肝胰十二指肠切除术在胆囊癌和肝外胆管癌治疗中的当前作用:一项系统评价
World J Gastrointest Oncol. 2021 Jun 15;13(6):625-637. doi: 10.4251/wjgo.v13.i6.625.
10
The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection.主要肝切除术中厌氧菌的患病率及临床意义
Antibiotics (Basel). 2021 Jan 31;10(2):139. doi: 10.3390/antibiotics10020139.

本文引用的文献

1
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.B 型图像引导超声衰减参数可准确检测慢性肝病中的肝脂肪变性。
Ultrasound Med Biol. 2018 Nov;44(11):2223-2232. doi: 10.1016/j.ultrasmedbio.2018.06.017. Epub 2018 Aug 2.
2
Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma.肝门部胆管癌根治术后患者总生存期的预后因素的荟萃分析。
Br J Surg. 2018 Oct;105(11):1408-1416. doi: 10.1002/bjs.10921. Epub 2018 Jul 12.
3
Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝脏脂肪含量的无创定量检测方法
J Clin Transl Hepatol. 2018 Jun 28;6(2):217-221. doi: 10.14218/JCTH.2018.00021. Epub 2018 Jun 22.
4
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.多参数磁共振成像定量诊断肝脏疾病:一项两中心横断面观察性研究。
Sci Rep. 2018 Jun 15;8(1):9189. doi: 10.1038/s41598-018-27560-5.
5
Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.肝切除术后肝衰竭的最新进展:预测和避免术后肝衰竭的策略
J Clin Transl Hepatol. 2018 Mar 28;6(1):97-104. doi: 10.14218/JCTH.2017.00060. Epub 2017 Nov 30.
6
Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.根治性手术后肝门部胆管癌早期复发的定义:来自美国肝外胆管恶性肿瘤联盟的多机构研究
World J Surg. 2018 Sep;42(9):2919-2929. doi: 10.1007/s00268-018-4530-0.
7
Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.肝门部胆管癌的现代检查与扩大切除术:荷兰癌症研究所的经验
Langenbecks Arch Surg. 2018 May;403(3):289-307. doi: 10.1007/s00423-018-1649-2. Epub 2018 Jan 19.
8
Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.根治性切除后肝门周围胆管癌的复发:采用密切术后随访方法的大型队列分析。
Surgery. 2018 Apr;163(4):732-738. doi: 10.1016/j.surg.2017.08.011. Epub 2018 Jan 11.
9
Impact of liver volume and liver function on posthepatectomy liver failure after portal vein embolization- A multivariable cohort analysis.肝体积和肝功能对门静脉栓塞术后肝切除术后肝衰竭的影响——一项多变量队列分析。
Ann Med Surg (Lond). 2017 Dec 7;25:6-11. doi: 10.1016/j.amsu.2017.12.003. eCollection 2018 Jan.
10
Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma.使用瞬时弹性成像技术预测乙型肝炎相关肝细胞癌患者肝切除术后肝衰竭
BMC Gastroenterol. 2017 Dec 29;17(1):171. doi: 10.1186/s12876-017-0732-4.

肝门部胆管癌切除术:技术复杂性与结果

Resection for Klatskin tumors: technical complexities and results.

作者信息

Capobianco Ivan, Rolinger Jens, Nadalin Silvio

机构信息

Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.

出版信息

Transl Gastroenterol Hepatol. 2018 Sep 18;3:69. doi: 10.21037/tgh.2018.09.01. eCollection 2018.

DOI:10.21037/tgh.2018.09.01
PMID:30363698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6182019/
Abstract

Klatskin's tumors, actually-redefined as perihilar cholangiocarcinoma (phCCA) do represent 50-70% of all CCAs and develop in a context of chronic inflammation and cholestasis of bile ducts. Surgical resection provides the only chance of cure for this disease but is technically challenging because of the complex, intimate and variable relationship between biliary and vascular structures at this location. Five years survival rates range between 25-45% (median 27-58 months) in case of R0 resection and 0-23% (median 12-21 months) in case of R1 resection respectively. It should be noted that the major costs of high radicality are represented by relative high morbidity and mortality rates (i.e., 20-66% and 0-9% respectively). Considering the fact that radical resection may represent the only curative treatment of phCCA, we focused our review on surgical planning and techniques that may improve resectability rates and outcomes for locally advanced phCCA. The surgical treatment of phCCA can be successful when following aspects have been fulfilled: (I) accurate preoperative diagnostic aimed to identify the tumor in all its details (localization and extension) and to study all the risk factors influencing a posthepatectomy liver failure (PHLF): i.e., liver volume, liver function, liver quality, haemodynamics and patient characteristics; (II) High end surgical skills taking in consideration the local extension of the tumor and the vascular invasion which usually require an extended hepatic resection and often a vascular resection; (III) adequate postoperative management aimed to avoid major complications (i.e., PHLF and biliary complications). These are technically challenging operations and must be performed in a high volume centres by hepato-biliary-pancreas (HBP)-surgeons with experience in microsurgical vascular techniques.

摘要

实际上,克氏壶腹周围癌(Klatskin's tumors)现被重新定义为肝门部胆管癌(perihilar cholangiocarcinoma,phCCA),占所有胆管癌的50%-70%,在胆管慢性炎症和胆汁淤积的背景下发生。手术切除是治愈该疾病的唯一机会,但由于该部位胆管和血管结构之间复杂、紧密且多变的关系,手术在技术上具有挑战性。R0切除的5年生存率分别在25%-45%(中位生存期27-58个月)之间,R1切除的5年生存率在0%-23%(中位生存期12-21个月)之间。需要注意的是,高根治性手术的主要代价是相对较高的发病率和死亡率(分别为20%-66%和0%-9%)。鉴于根治性切除可能是phCCA唯一的治愈性治疗方法,我们的综述重点关注可能提高局部晚期phCCA可切除率和治疗效果的手术规划和技术。当满足以下方面时,phCCA的手术治疗可能会成功:(I)准确的术前诊断,旨在详细识别肿瘤(定位和范围),并研究所有影响肝切除术后肝衰竭(PHLF)的危险因素,即肝脏体积、肝功能、肝脏质量、血流动力学和患者特征;(II)高超的手术技巧,考虑到肿瘤的局部范围和血管侵犯,这通常需要扩大肝切除,且常常需要血管切除;(III)充分的术后管理,旨在避免主要并发症(即PHLF和胆道并发症)。这些手术在技术上具有挑战性,必须由具有显微外科血管技术经验的肝-胆-胰(HBP)外科医生在大容量中心进行。